The effect of cyclic nucleotide analog drugs on the mediators release from basophils

Eskandari, Nahid; Bastan, Reza; Esfahani, Seyyed; Peachell, Peter T

The effect of cyclic nucleotide analog drugs on the mediators release from basophils

Authors

¹ Department of Immunology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

² Razi Karaj Institute, Karaj, Iran

³ Department of Immunology, Cellular and Molecular Immunology Research Center, Physiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

⁴ Department of Respiratory Medicine, University of Sheffield, United Kingdom

Abstract

Background: The cyclic nucleotides, cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), are intracellular second messengers that play an important role in modulating inflammatory cells involved in allergic diseases. In general, cAMP suppresses the activity of immune and inflammatory cells. We aim to evaluate the roles of cAMP and cGMP in regulating basophil activity.
Materials and Methods: Basophil-enriched preparations were incubated with analogs and then challenged with anti-IgE or IL-3 (4 or 24 hours). Supernatants were assayed for histamine, IL-4, and IL-13 release. The effects of Sp-8-CPT-cAMPS and Sp-8-CPT-cGMPS on IL-3-dependent mediator release from basophils were determined. The cells were pre-incubated with an analog and then incubated with IL-3 for 24 hours.
Results: Sp-8-CPT-cAMPS was an effective (P < 0.05) inhibitor of IL-4, IL-13, and histamine release from basophils. However, paradoxically, Sp-8-CPT-cGMPS enhanced histamine release and IL-13 generation, but by contrast, had little effect on IL-4 generation. Sp-8-CPT-cGMPS inhibited cytokine generation, but enhanced the release of histamine release to a modest extent.
Conclusion: This study shows that the cAMP/protein kinase A (PKA) pathway may be inhibitory to the IgE- and non-IgE-dependent release of mediators from basophils.

Keywords

References

1.	Conolly ME. Cyclic nucleotides, beta receptors, and bronchial asthma. Adv Cyclic Nucleotide Res 1980;12:151-9.
2.	Barnes PJ. Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J 1995;8:457-62.
3.	Aleksijevic A, Lang JM, Giron C, Stoclet JC, Mayer S, Oberling F. Alterations of peripheral blood lymphocyte cyclic AMP and cyclic GMP in untreated patients with hodgkin's disease. Clin Immunol Immunopathol 1983;26:398-405.
4.	Zhikharev SS, Mineev VN. Characteristics of cyclic nucleotide metabolism in the leukocytes of patients with bronchial asthma. Ter Arkh 1980;52:89-93.
5.	He L, Li TP, Zhu LH. Alveolar fluid clearance and changes of alveolar type II cell cAMP and cGMP levels in rats with oleic acid-induced acute respiratory distress syndrome. Nan Fang Yi Ke Da Xue Xue Bao 2008;28:513-6.
6.	DiFrancesco D, Tortora P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 1991;351:145-7.
7.	Brunet LJ, Gold GH, Ngai J. General anosmia caused by a targeted disruption of the mouse olfactory cyclic nucleotide-gated cation channel. Neuron 1996;17:681-93.
8.	Collins SP, Uhler MD. Cyclic AMP - and cyclic GMP-dependent protein kinases differ in their regulation of cyclic AMP response element-dependent gene transcription. J Biol Chem 1999;274:8391-404.
9.	Shaywitz AJ, Greenberg ME. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999;68:821-61.
10.	Ianculescu I, Wu DY, Siegmund KD, Stallcup MR. Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgen-regulated gene expression in advanced prostate cancer cells. J Biol Chem 2012;287:4000-13.
11.	Zuloaga R, Fuentes EN, Molina A, Valdes JA. The cAMP response element binding protein (CREB) is activated by insulin-like growth factor-1 (IGF-1) and regulates myostatin gene expression in skeletal myoblast. Biochem Biophys Res Commun 2013;440:258-64.
12.	Peachell PT, MacGlashan DW Jr., Lichtenstein LM, Schleimer RP. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988;140:571-9.
13.	Selwa E, Laine E, Malliavin TE. Differential role of calmodulin and calcium ions in the stabilization of the catalytic domain of adenyl cyclase CyaA from Bordetella pertussis. Proteins 2012;80:1028-40.
14.	Schmidt HH, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1993;1178:153-75.
15.	Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide: The NO-cyclic GMP signal transduction system. Adv Pharmacol 1994;26:19-33.
16.	Murad F. The nitric oxide-cyclic GMP signal transduction system for intracellular and intercellular communication. Recent Prog Horm Res 1994;49:239-48.
17.	Schwede F, Maronde E, Genieser H, Jastorff B. Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol Ther 2000;87:199-226.
18.	MacGlashan D Jr. Signal transduction: Mechanisms in basophils. J Allergy Clin Immunol 1994;94:1146-51.
19.	Cheng KN, Redrup MJ, Barrow A, Williams PN. Validation of a liquid chromatographic tandem mass spectrometric method for the determination of sumatriptan in human biological fluids. J Pharm Biomed Anal 1998;17:399-408.
20.	Katsuki S, Arnold WP, Murad F. Effects of sodium nitroprusside, nitroglycerin, and sodium azide on levels of cyclic nucleotides and mechanical activity of various tissues. J Cyclic Nucleotide Res 1977;3:239-47.
21.	Arnold WP, Mittal CK, Katsuki S, Murad F. Nitric oxide activates guanylate cyclase and increases guanosine 3': 5'-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci USA 1977;74:3203-7.
22.	Lincoln TM, Cornwell TL. Intracellular cyclic GMP receptor proteins. FASEB J 1993;7:328-38.
23.	Tsuchida S, Sudo M, Muramatsu I. Stimulatory and inhibitory effects of sodium nitroprusside on soluble guanylate cyclase. Life Sci 1996;58:829-32.
24.	Yao M, Roberts DD, Isenberg JS. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP. Pharmacol Res 2011;63:13-22.
25.	Conley BA, Egorin MJ, Tait N, Rosen DM, Sausville EA, Dover G, et al. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin Cancer Res 1998;4:629-34.
26.	Joshi SS, Sinangil F, Sharp JG, Mathews NB, Volsky DJ, Brunson KW. Effects of differentiation inducing chemicals on in vivo malignancy and NK susceptibility of metastatic lymphoma cells. Cancer Detect Prev 1988;11:405-17.
27.	Hutt-Taylor SR, Harnish D, Richardson M, Ishizaka T, Denburg JA. Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60. Blood 1988;71:209-15.
28.	Kawamoto T, Gohda E, Iji H, Fujiwara M, Yamamoto I. SKW 6.4 cell differentiation induced by interleukin 6 is stimulated by butyrate. Immunopharmacology 1998;40:119-30.
29.	Spicuzza L, Belvisi MG, Birrell MA, Barnes PJ, Hele DJ, Giembycz MA. Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase. Br J Pharmacol 2001;133:1201-12.
30.	Butt E, Eigenthaler M, Genieser HG. (Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor. Eur J Pharmacol 1994;269:265-8.
31.	Gamm DM, Francis SH, Angelotti TP, Corbin JD, Uhler MD. The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms. J Biol Chem 1995;270:27380-8.
32.	Siednienko J, Nowak J, Moynagh PN, Gorczyca WA. Nitric oxide affects IL-6 expression in human peripheral blood mononuclear cells involving cGMP-dependent modulation of NF-kB activity. Cytokine 2011;54:282-8.
33.	Szadujkis-Szadurska K, Grzesk G, Szadujkis-Szadurski L, Gajdus M, Matusiak G. Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion. Exp Ther Med 2013;5:616-20.
34.	Peh KH, Moulson A, Wan BY, Assem EK, Pearce FL. Role of nitric oxide in histamine release from human basophils and rat peritoneal mast cells. Eur J Pharmacol 2001;425:229-38.
35.	Wan BY, Peh KH, Ho M, Assem ES. Effects of nitric oxide and hydrogen peroxide on histamine release from RBL-2H3 cells. Biochem Pharmacol 2001;62:1537-44.
36.	Evilevitch V, Norrgren K, Greiff L, Wollmer P. Modulation of the inflammatory response to histamine by terbutaline and sodium nitroprusside in guinea-pig skin. Clin Physiol Funct Imaging 2005;25:340-3.

Advanced Biomedical Research